Moving forward with species distributions

Moving forward with reactive oxygen species involvement in antimicrobial lethality.

Support for the contribution of reactive oxygen species (ROS) to antimicrobial lethality has been refined and strengthened. Killing by diverse antimicrobials is enhanced by defects in genes that protect against ROS, inhibited by compounds that block hydroxyl radical accumulation, and is associated with surges in intracellular ROS. Moreover, support has emerged for a genetic pathway that control...

Moving Forward

.......Having reached the end of my second term as editor in chief, the time has come for Micro to move forward to the next phase of its evolution. I am delighted to announce that Dr. Erik Altman from IBM Research is the new Micro EIC. Erik is an accomplished and highly respected industry architect and researcher who has held numerous leadership positions within the computing community. He has ...

Moving forward.

Moving forward with randomized controlled trials.

A randomized controlled trial (RCT) is the most powerful tool for determining the cause-effect relationship between an intervention and an outcome. RCTs typically include random allocation to intervention and control groups, a blinding plan for trialists, assessors and/or participants, identical treatment groups except for the experimental ingredients, and an intent-to-treat analysis. RCTs are ...

Moving Forward with Electricity Tariff Reform

For the better part of the past century, residential customers in the United States and many other countries have paid for electricity through a twopart tariff that has collected most of the revenue through a flat volumetric charge—that is, flat electricity rates paid in cents per kilowatt hour (¢/ kWh). In contrast, a large share of the cost of producing and delivering electricity does not var...